Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors.
Beauverie
P
P
Taburet
A M
AM
Dessalles
M C
MC
Furlan
V
V
Touzeau
D
D
D000328:Adult; D004347:Drug Interactions; D016903:Drug Monitoring; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006679:HIV Seropositivity / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008691:Methadone / Q000378:metabolism* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000534:rehabilitation*
D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D008691:Methadone